Table 4

GDP and treatment-related variables in the QUEST–RA study in Europe and other countries, in descending order of GDP

CountryGDP 2005 per capita US$1000Patients taking DMARD ever, %Delay to start DMARD, months, medianNo of DMARD ever takenMethotrexate ever, % of patientsPrednisone ever, % of patientsBiologicals ever, % of patientsAny DMARD, % of disease durationMethotrexate, % of disease durationBiologicals, % of disease duration
    Europe
    Ireland48.798.010.02.493714255.728.96.6
    Denmark47.999.010.02.886442365.625.52.9
    Sweden39.694.012.02.884693373.731.17.2
    The Netherlands38.999.05.02.392302387.645.04.4
    Finland37.3100.07.04.0867417109.625.72.2
    UK37.395.012.02.483542051.324.61.9
    France35.099.08.03.787835377.031.08.9
    Germany33.992.015.02.780542966.528.86.3
    Italy30.596.09.02.481722766.928.92.9
    Spain26.198.013.02.887682767.430.94.4
    Greece25.6100.07.02.9949454104.250.814.6
    Hungary10.996.012.02.685581654.320.10.7
    Estonia10.398.012.02.88376167.423.80.3
    Poland8.099.04.03.089801064.026.30.9
    Lithuania7.596.013.02.384971145.321.21.7
    Latvia7.098.024.02.292792352.928.01.6
    Serbia3.596.011.02.06988264.625.20.3
    Kosovo3.5100.03.02.08295182.436.80.2
Non-Europe
    USA41.9989.02.185773383.839.58.5
    Canada35.29511.03.076622877.622.15.0
    UAE32.48811.01.873561070.231.31.9
    Russia5.38810.01.873411864.028.69.7
    Turkey59912.02.48975775.333.40.7
    Brazil4.81008.03.0988127115.757.63.7
    Argentina4.78813.01.56883346.324.50.5
Total9792.785712371.630.83.9
  • DMARD, disease-modifying antirheumatic drug; GDP, gross domestic product; UAE, United Arab Emirates.